Furaprofen
Furaprofen (R803) is an effective HCV replication inhibitor. Furaprofen (R803) is substantially more potent against genotype 1a and 1b replicons (EC50, ~30 nM) than against the genotype 2a replicon (EC50, ~1,000 nM) .
Product Specifications
CAS Number
[67700-30-5]
Product Name Alternative
R803
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/R803.html
Purity
99.78
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
OC(C(C1=CC=CC2=C1OC=C2C3=CC=CC=C3)C)=O
Molecular Formula
C17H14O3
Molecular Weight
266.29
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Huang P, et al. Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication. Antimicrob Agents Chemother. 2008 Apr;52 (4) :1419-29.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
217575 25 mg
Mycobacterium Bactericide, TCA1 (Ethyl- (2- (benzo[d]thiazole-2-carboxamido) thiophene-3-carbonyl) carbamate, Ethyl- ((2- ((1,3-benzothiazol-2-ylcarbonyl) amino) -3-thienyl) carbonyl) carbamate, Mtb Inhibitor, Mycobacteria DprE1 Inhibitor, Mycobacteria MoeW Inhibitor) discontinued
Ask
View Details